Remedica announces the departure of Chief Executive Officer Michalis Neoptolemou, who leaves with the company’s deepest gratitude, having been a core part of its hugely successful journey over the last 10 years.
He joined the company in 2014, and served as CEO over the last five years, transforming Remedica from a family business into an international corporation, with a presence in over 100 countries. Under his leadership, Remedica expanded its product range dramatically, and made important investments in its manufacturing capabilities.
Dr Neoptolemou safely guided the company through two ownership transitions: first from family hands to a South African conglomerate, and then returning Remedica to Cyprus-based private ownership, backed by international investors, with long-term commitment to growth, innovation and investment. Today, Remedica is one of the largest exporters in Cyprus, recognised for its quality and outstanding service.
His departure sets up Remedica for its next stage of growth. The foundations for this have already been laid: over the last two years, Remedica has initiated the biggest investment programme in its history, investing in new product development and expanded manufacturing capabilities. The Board and executive leadership team will ensure business continuity and remain committed to growth and innovation.